About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Phoenix | 138 Studies

Clinical Trials Ovarian CancerPhoenix

Ovarian Cancer Clinical Trials in Phoenix

Find 138 clinical trials for ovarian cancer near Phoenix, Arizona. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 138 trials

UnknownChemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerThis trial studies the chemotherapy toxicity on quality of life in older patients with stage I, stage II, stage III, or stage IV ovarian epithelial, primary peritoneal cavity, or…NCT01366183·Birmingham, Alabama and 356 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedA Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal CancerThe MILO Study (MEK Inhibitor in Low-grade Serous Ovarian Cancer) is a Phase 3 study during which patients with recurrent or persistent low-grade serous (LGS) carcinomas of the…NCT01849874·Phoenix, Arizona and 225 others

Active not recruitingRelacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerThe primary objectives of this study are to evaluate progression-free survival (PFS) by blinded independent central review (BICR) and overall survival (OS) (evaluated…NCT05257408·Phoenix, Arizona and 115 others

TerminatedA Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian CancerThe purpose of the dose escalation phase is to evaluate the safety profile of escalating doses and dose schedules of NXP800.NCT05226507·Phoenix, Arizona and 21 others

RecruitingCATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer.NCT06690775·Phoenix, Arizona and 65 others

TerminatedPaclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00023907·Phoenix, Arizona and 43 others

CompletedA Trial Evaluating TG4050 in Ovarian Carcinoma.This is a multicenter, open-label, single arm phase I study evaluating the safety and tolerability as well as some activity parameters of TG4050 in patients with ovarian…NCT03839524·Phoenix, Arizona and 5 others

Active not recruitingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneThis phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating…NCT03660826·Birmingham, Alabama and 760 others

TerminatedA Study of PY314 in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, first in human, Phase 1a/1b study of PY314 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are refractory…NCT04691375·Phoenix, Arizona and 22 others

CompletedA Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian CancerThis multicenter, open-label, dose-escalating study will assess the safety, tolerability, and pharmacokinetics of DMOT4039A in participants with unresectable pancreatic or…NCT01469793·Phoenix, Arizona and 5 others

Active not recruitingCarboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis phase I trial studies the side effects and best dose of gemcitabine hydrochloride and berzosertib when given together with carboplatin in treating patients with ovarian…NCT02627443·Phoenix, Arizona and 13 others

Active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid…NCT06607185·Birmingham, Alabama and 44 others

CompletedCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase III trial studies carboplatin, paclitaxel, and bevacizumab to see how well they work compared to carboplatin, paclitaxel, and placebo in treating patients…NCT00262847·Anniston, Alabama and 631 others

TerminatedCombination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003378·Birmingham, Alabama and 63 others

TerminatedTopotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005029·Birmingham, Alabama and 73 others

CompletedAn Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyThis is a phase III randomized study comparing induction treatments of Gemcitabine and Carboplatin versus Paclitaxel and Carboplatin, with or without consolidation therapy for…NCT00191646·Phoenix, Arizona and 54 others

TerminatedVaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial CancerRATIONALE: Vaccines made from tumor tissue may make the body build an immune response and kill tumor cells.NCT00003386·Birmingham, Alabama and 59 others

CompletedCombination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003322·Birmingham, Alabama and 66 others

TerminatedDocetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004037·Birmingham, Alabama and 66 others

TerminatedLiposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003380·Birmingham, Alabama and 62 others

Page 1 of 7Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia